Literature DB >> 14500343

Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy.

Rachel L Morris1, Kashif Azizuddin, Minh Lam, Jeffrey Berlin, Anna-Liisa Nieminen, Malcolm E Kenney, Anna C S Samia, Clemens Burda, Nancy L Oleinick.   

Abstract

Phthalocyanine (Pc) 4, like many photosensitizers for photodynamic therapy (PDT), localizes to intracellular membranes, especially mitochondria. Pc 4-PDT photodamages Bcl-2 and Bcl-xL, antiapoptotic proteins interacting with the permeability transition pore complex that forms at contact sites between the inner and outer mitochondrial membranes. These complexes and the inner membrane are unique in containing the phospholipid cardiolipin. Nonyl-acridine orange (NAO) is a specific probe of cardiolipin. Here we show evidence for fluorescence resonance energy transfer from NAO to Pc 4, defining a binding site for the photosensitizer. This observation establishes an innovative tool for exploring the localization of other photosensitizers and additional fluorescent, mitochondrion-localizing drugs having appropriate spectral properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500343

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

Authors:  Yu Cheng; Joseph D Meyers; Richard S Agnes; Tennyson L Doane; Malcolm E Kenney; Ann-Marie Broome; Clemens Burda; James P Basilion
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

2.  Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4.

Authors:  Myriam E Rodriguez; Junhwan Kim; Grace B Delos Santos; Kashif Azizuddin; Jeffrey Berlin; Vernon E Anderson; Malcolm E Kenney; Nancy L Oleinick
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

Review 3.  Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.

Authors:  Sunaina Singh; Amit Aggarwal; N V S Dinesh K Bhupathiraju; Gianluca Arianna; Kirran Tiwari; Charles Michael Drain
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

4.  Mitochondrial Redox Opto-Lipidomics Reveals Mono-Oxygenated Cardiolipins as Pro-Apoptotic Death Signals.

Authors:  Gaowei Mao; Feng Qu; Claudette M St Croix; Yulia Y Tyurina; Joan Planas-Iglesias; Jianfei Jiang; Zhentai Huang; Andrew A Amoscato; Vladimir A Tyurin; Alexandr A Kapralov; Amin Cheikhi; John Maguire; Judith Klein-Seetharaman; Hülya Bayır; Valerian E Kagan
Journal:  ACS Chem Biol       Date:  2016-01-05       Impact factor: 5.100

5.  Death pathways associated with photodynamic therapy.

Authors:  David Kessel
Journal:  Med Laser Appl       Date:  2006-11-15

6.  CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells.

Authors:  Si-Jia He; Jia Cao; Yong-Sheng Li; Jia-Chun Yang; Min Zhou; Chun-Ying Qu; Yi Zhang; Feng Shen; Ying Chen; Ming-Ming Li; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

7.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

8.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

9.  Studies on the subcellular localization of the porphycene CPO.

Authors:  David Kessel; Mary Conley; M Graça H Vicente; John J Reiners
Journal:  Photochem Photobiol       Date:  2005 May-Jun       Impact factor: 3.421

10.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.